Dr. Husna Ismail

Husna Ismail is a South African clinical microbiologist and public health researcher affiliated with the National Institute for Communicable Diseases and the National Health Laboratory Service. Her work centres on laboratory-based surveillance of infectious diseases, with a strong focus on antimicrobial resistance, fungal infections, and vaccine-preventable diseases. She has contributed extensively to national surveillance platforms that inform clinical guidelines and public health policy.

Her publications highlight expertise in molecular epidemiology and genomic characterization of priority pathogens, including Candida auris, Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Through outbreak investigations in neonatal and tertiary care settings, she has advanced understanding of transmission dynamics, resistance mechanisms, and infection prevention strategies in resource-limited environments.

Ismail has also led influential studies on cryptococcal disease and pneumococcal vaccination impact, demonstrating the real-world benefits of antifungal access programmes and conjugate vaccines across age groups. By integrating clinical outcomes with laboratory surveillance data, her research provides critical evidence for treatment optimization, antimicrobial stewardship, and vaccine policy in South Africa and similar settings.